Speaker
Senior Director, Translational Operations & Regulatory Integration, Sarepta Therapeutics
Jaime Fensterl, Senior Director, Translational Operations & Regulatory Integration at Sarepta Therapeutics, is speaking at Biomarker Operations & Biospecimen Management Summit (Boston, United States of America, 16–17 Nov 2026) in the session “Reducing Pre-Analytical Variability: Building Site Management Strategies That Deliver High-Quality Biomarker Samples at Scale”.
16–17 Nov 2026Boston, United States of America
Chief (Acting) Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program, National Institute of Health Science
Senior Manager, Precision Medicine & Clinical Operations Lead, Regeneron Pharmaceuticals
Executive Director & Head, Consent, Biospecimen & Imaging Management, Bristol Myers Squibb
Associate Director, Biomarker & Diagnostic Operations, Johnson & Johnson
Director, Biorepositories Program, Mayo Clinic
Director, Biosample Operations, Arcus Biosciences
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jaime Fensterl, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].